|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income/(expense): | |||||
| Interest income, net | |||||
| Interest income | |||||
| Interest expense | |||||
| Foreign exchange loss, net | |||||
| Change in fair value of 2022 USD Financing Warrants | |||||
| Other (expense)/income | |||||
| Gain on extinguishment of contribution payable | |||||
| Other expense | |||||
| Total other expense, net | |||||
| Loss before income taxes | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Other comprehensive loss: | |||||
| Unrealized gain on investments | |||||
| Gain/(loss) on foreign currency translation | |||||
| Comprehensive loss | |||||
| Net loss per common share, basic | |||||
| Net loss per common share, diluted | |||||
| Weighted-average common shares, basic | |||||
| Weighted-average common shares, diluted | |||||
Loading...